Strategically located in the Princeton area, our leased facility consists of professional office space and a scientific laboratory space. The location represents a sub-lease office space that was previously occupied by a larger pharmaceutical company. The lease comes with first right of refusal for the additional area and allows for seamless expansion for both R&D and warehouse as and when necessary.
Dynamic has identified a number of well-known generic drug products for its pipeline in several therapeutic areas including in multiple sclerosis, anticoagulant, blood plasma products and ophthalmics. Each candidate molecule either is in shortage in the United States, or is an orphan drug, has technical barriers to entry as in the case of biosimilars or has side effects that may be addressed by innovative drug delivery approaches.
The pipeline products either address an unmet drug delivery need or a major safety issue.